Your Weekly Guide to Ozempic: Understanding How Many Shots You Take

Last reviewed: June 30, 2026

Last updated: June 30, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide injection therapy follows a structured weekly dosing schedule that begins conservatively and adjusts upward based on your individual response and tolerance. Most patients start their first injection at 0.25 mg once weekly, with dose increases happening every four weeks until reaching their maintenance level. Understanding this gradual approach helps you prepare for what to expect during your first weeks of treatment.

How the Weekly Semaglutide Injection Schedule Works

Semaglutide injections are given subcutaneously (under the skin) on the same day each week, making the therapy straightforward to integrate into your routine. The standard titration protocol begins at 0.25 mg and progresses through predetermined dose increases every seven days for the first month, then monthly increases thereafter. Your first injection marks the beginning of a four to five-month ramp-up period designed to let your body adapt while minimizing side effects and building tolerance to the medication's appetite-suppressing effects.

The weekly schedule aligns with your body's natural weekly rhythm and allows your healthcare provider to monitor your response before advancing to the next dose level. Patients typically follow their chosen injection day consistently—for example, every Thursday morning or Friday evening—establishing a predictable pattern that reduces the chance of missed doses. This regularity also makes it easier to track your progress and identify any patterns in how you respond to the medication.

Understanding the Four-Week Titration Phases

Phase one begins with your 0.25 mg starting dose, which primes your system to the medication while you assess your individual tolerance and early side effects. After four weeks, if you're tolerating the medication well, your dose advances to 0.5 mg for the second month. This measured pace gives your body time to adjust to each new dose level before moving forward, reducing the likelihood of significant nausea or gastrointestinal upset.

Month three typically involves a jump to 1.0 mg weekly, and month four moves to 1.7 mg, which is considered a standard maintenance dose for many patients pursuing weight loss. Some individuals continue beyond 1.7 mg to 2.4 mg in month five, though this represents the maximum approved dose and is tailored to your specific weight loss goals and tolerance profile. The entire progression is designed so that your dose may increase with your advancing treatment, but your monthly cost remains fixed at the same rate with PlexusDx.

Recognizing Individual Variation in Semaglutide Response

The PlexusDx Precision Peptide Genetic Test analyzes FTO — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

Testing identifies whether variants like GLP1R rs6923761 or GIPR rs1800437 might affect your medication responsiveness, allowing your healthcare provider to adjust your treatment strategy proactively. Some patients reach their target dose at 1.0 mg and maintain excellent results, while others require advancement to 2.4 mg for comparable weight loss—this variation is normal and genetically informed. Understanding your individual peptide pathway predispositions helps explain why your neighbor's results may differ from yours, even when following the identical injection schedule.

What to Expect During Each Weekly Injection

Your first injection involves a small subcutaneous needle injection—typically in your abdomen, thigh, or upper arm—that takes less than 10 seconds to complete. You'll use a pre-filled pen or syringe designed for single-use weekly dosing, with clear dial indicators showing your prescribed dose amount. Most patients report the needle sensation as minimal, comparable to a routine vaccination, with the injection site often showing no visible mark or only mild temporary redness.

As your dose increases weekly, you may notice progressive changes in appetite, food cravings, and satiety signals beginning within the first few days after each injection. Early weeks often bring nausea or mild gastrointestinal changes, but these typically diminish as your body adjusts—staying hydrated, eating smaller meals, and consuming protein-rich foods can ease this transition. By your third or fourth week at any given dose, most patients report stabilized side effects and normalized appetite suppression, signaling readiness for the next dose advance if scheduled.

Accessing Semaglutide Injections Through PlexusDx

PlexusDx compounds pharmaceutical-grade semaglutide through licensed 503A compounding pharmacies serving all 50 states without insurance requirements or membership fees. Compounded semaglutide injections are $189/mo month-to-month, or from $149/mo on the 6-month plan across all dose levels, meaning your cost remains stable whether you're at 0.25 mg or 2.4 mg—your dose may increase, but your price won't. The medication is HSA and FSA eligible, and PlexusDx provides detailed shipment tracking and refrigeration guidance to ensure your weekly injections arrive ready to use.

After your first month of treatment, you have the option to add the Precision Peptide Genetic Test for $298, which analyzes your genetic predispositions across peptide pathways relevant to weight management and GLP-1 response. This genetic insight helps your provider personalize not only your semaglutide dosing but also consideration of additional compounds like tirzepatide or the GLP-Squared dual-compound injection if your response plateaus. PlexusDx's commitment to precision dosing means you're never guessing about whether you're on the right dose—your genetics and clinical response guide the entire process.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

How many semaglutide shots do I take per month?

You take one semaglutide injection per week, totaling four injections per month. Each injection delivers your weekly dose on the same day each week, making the schedule simple and predictable for most patients.

Will my semaglutide cost increase as my dose goes up?

No. PlexusDx's compounded semaglutide injections are $189/mo month-to-month, or from $149/mo on the 6-month plan and remain at that same flat rate regardless of your dose level. Your dose may need to go up—your price won't.

What clinical evidence supports weekly semaglutide dosing?

Clinical trials demonstrate that once-weekly subcutaneous semaglutide produces sustained weight loss of 10-15% over 68 weeks compared to placebo. The weekly schedule maintains stable medication levels in your bloodstream, optimizing appetite suppression while minimizing fluctuations in side effects.

Is PlexusDx semaglutide from a licensed pharmacy?

Yes. PlexusDx sources all semaglutide injections from licensed 503A compounding pharmacies, which maintain the highest pharmaceutical standards for medication preparation and quality assurance. These are not mass-manufactured medications but precision-compounded formulations prepared under strict FDA oversight.

How does the Precision Peptide Genetic Test improve my semaglutide therapy?

No — the Precision Peptide Genetic Test does not predict your response to semaglutide or any specific medication. It analyzes pathway-level variants (GIPR (rs1800437)) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Lifemd Ozempic
• Eden Ozempic
• Ro Ozempic
• Mochi Ozempic

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.